IMS Names Kimberly Gray Chief Privacy Officer, Americas.
IMS Health IMS Health (NYSE: RX) is an international consulting and data services company that supplies the pharmaceutical industry with sales data and consulting services. IMS Health was founded in 1954 by Bill Frohlich and David Dubow. (NYSE NYSE
See: New York Stock Exchange : RX), the world's leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the appointment of Kimberly S. Gray, a recognized leader in corporate privacy, as chief privacy officer, Americas. Gray will direct all privacy-related activities for IMS's operating companies in the U.S., Canada and Latin America Latin America, the Spanish-speaking, Portuguese-speaking, and French-speaking countries (except Canada) of North America, South America, Central America, and the West Indies. , guiding the company's privacy strategy, management and implementation while supporting its leadership efforts in these areas.
Gray, who brings more than a decade of experience in privacy and data protection to IMS (1) See IP Multimedia Subsystem.
(2) (Information Management System) An early IBM hierarchical DBMS for IBM mainframes. IMS was widely implemented throughout the 1970s under MVS and continues to be used under z/OS. , will ensure compliance with all applicable privacy laws and work closely with the company's internal and external stakeholders Stakeholders
All parties that have an interest, financial or otherwise, in a firm-stockholders, creditors, bondholders, employees, customers, management, the community, and the government. , including employees, clients, suppliers and vendors, as well as legislators, government agencies, policy organizations, and healthcare researchers. In this position, she will represent IMS in determining responsible uses of the company's market information, maintaining an appropriate balance between privacy and transparency, enabling increased use of IMS information to improve healthcare outcomes, and ensuring appropriate safeguards are employed to secure sensitive information.
"With federal policy rapidly moving toward greater healthcare transparency and the use of information to improve quality and treatment outcomes, it is imperative that patient privacy remains sacrosanct sac·ro·sanct
Regarded as sacred and inviolable.
[Latin sacrs ," said Bill Nelligan, IMS president, Americas. "Kim brings a wealth of experience to this role and has led corporate privacy compliance programs and provided testimony before government and regulatory bodies about the legal and business impact of privacy legislation. We look forward to Kim's leadership in upholding IMS's 50-plus year tradition of maintaining the most rigorous privacy standards."
Prior to joining IMS, Gray was chief privacy officer at Highmark, a Pennsylvania health insurance company, where she was accountable for safeguarding approximately 27 million members' health information. Gray has a J.D. from Penn State University's Dickinson School of Law In 2005 a dispute over whether or not to move the Dickinson School of Law to Penn State's University Park campus in State College, Pennsylvania led to a "dual campus" proposal being enacted. , a B.A. in Psychology from Shippensburg University and certification as a Certified Information Privacy Professional (CIPP CIPP Cured In Place Pipe (pipe lining)
CIPP Certified Information Privacy Professional
CIPP Critical Infrastructure Protection Project
CIPP Canadian International Peace Project
CIPP Cast in Place Pipe ). Additionally, she has served on the boards of directors for the Health Information Trust Alliance and International Association of Privacy Professionals The International Association of Privacy Professionals (IAPP), headquartered in York, Maine, is a global association of privacy and security professionals. With more approximately 4,000 individual and corporate members in 23 countries, the IAPP seeks to define, promote and improve .
Operating in more than 100 countries, IMS Health is the world's leading provider of market intelligence to the pharmaceutical and healthcare industries. With $2.3 billion in 2008 revenue and more than 50 years of industry experience, IMS offers leading-edge market intelligence products and services that are integral to clients' day-to-day operations, including product and portfolio management capabilities; commercial effectiveness innovations; managed care and consumer health offerings; and consulting and services solutions that improve productivity and the delivery of quality healthcare worldwide. Additional information is available at http://www.imshealth.com.